Reduced Intra- and Extracellular Circulating Postprandial Lysosomal Acid Lipase Activity in Patients with MASLD

Monica Mischitelli1, Eleonora Poggiogalle2, Giulia Tozzi3

  • 1Department of Translational and Precision Medicine, Sapienza University of Rome, 00185 Rome, Italy.

Metabolites
|December 27, 2024
PubMed
Summary

Patients with metabolic-dysfunction-associated steatotic liver disease (MASLD) exhibit lower lysosomal acid lipase (LAL) activity in blood and plasma. This reduction, particularly in carriers of the PNPLA3 variant, impairs the normal regulation of triglycerides after meals.